about
Epigenetics in breast cancer: what's new?Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencingCR Cistrome: a ChIP-Seq database for chromatin regulators and histone modification linkages in human and mouseSelective inhibition of tumor oncogenes by disruption of super-enhancersHistone chaperones link histone nuclear import and chromatin assemblyThe mutational landscape of chromatin regulatory factors across 4,623 tumor samples.Environmental-stress-induced Chromatin Regulation and its HeritabilitySilencing of the DNA mismatch repair gene MLH1 induced by hypoxic stress in a pathway dependent on the histone demethylase LSD1Aberrant transcriptional regulations in cancers: genome, transcriptome and epigenome analysis of lung adenocarcinoma cell lines.Inactivation of X-linked tumor suppressor genes in human cancer.ATRX contributes to epigenetic asymmetry and silencing of major satellite transcripts in the maternal genome of the mouse embryoRole of ATRX in chromatin structure and function: implications for chromosome instability and human diseaseCombinatorial patterning of chromatin regulators uncovered by genome-wide location analysis in human cells.A systematic method to identify modulation of transcriptional regulation via chromatin activity reveals regulatory network during mESC differentiation.A lesson learned from the H3.3K27M mutation found in pediatric glioma: a new approach to the study of the function of histone modifications in vivo?Everolimus for the treatment of pancreatic neuroendocrine tumors.The PML-Interacting Protein DAXX: Histone Loading Gets into the Picture.Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop.Histone mimics: digging down under.Computational and experimental methods to decipher the epigenetic codeInhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma.Emerging roles of ATRX in cancer.Persistent phosphorylation at specific H3 serine residues involved in chemical carcinogen-induced cell transformation.Translational research in neuroendocrine tumors: pitfalls and opportunities.Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumours.Whole-genome landscape of pancreatic neuroendocrine tumours.Identification of two independent nucleosome-binding domains in the transcriptional co-activator SPBP
P2860
Q26991779-8CD83922-91DD-4EAE-9F44-907118969514Q28275103-88AAEE60-1D61-4B2C-9587-A3A5C9911F15Q28660713-28378674-31B9-43E0-A690-B3C112BC8685Q29617301-2C66D5FD-CA25-4668-8743-FAFB96698DA1Q30422084-72D616BF-63BB-4397-AEEE-EB139336120AQ30580509-4D5DAB63-F7F2-4837-97E1-80EF8DF64053Q33914376-3A1EF4B7-2BD5-4A63-B5F9-F391ACF9B689Q33954219-55902C86-9181-48BB-AC78-56C115415A76Q34712122-D79FD708-4512-45FB-BA3F-7AFAED00E8B5Q35206452-90D159AD-DC34-464A-B8CE-FA6BA5C6CB7AQ35635068-20E98132-58EB-4539-8D85-1A3902CFB192Q35661042-FEE784EC-6F1D-4B4B-AD06-DA23B5937AC7Q35852758-6F705682-6BA9-440D-943D-043F8BB533FBQ36657122-5F056664-7718-4A2C-9291-2BF7865CEBF4Q37396891-1195FA0B-9FCA-4E9D-8E65-DDD45FB84E9EQ38032923-E939007C-0760-44B3-B956-0326289CD0EEQ38113966-6FB21844-9B8C-4AF3-A816-8F422685399AQ38168686-A17EB55F-0A33-4D43-80C4-B28AA78BE20DQ38223397-2EF4AEB2-4489-47E2-9BE7-D6562F729A43Q38258085-99F1688E-1E9B-4966-9E20-972D69A8C6E5Q38259785-E13E23C0-E555-42DC-A8BD-9AD72AF8C3E3Q38662646-2D93B82B-92CE-47F0-9AD9-2467B857A81BQ38725299-223A807B-67AF-4A87-A27B-C7F45AF046D0Q38958002-BB38627E-B021-4260-9386-F6F244DEE964Q42341753-66EE9848-E8BB-4CDA-BE25-A32E34476011Q51137102-754A2448-3B9A-44D9-B452-EC46B7580D9DQ57271949-A42626A5-656A-4E80-9665-F68BF03207EB
P2860
description
article publié dans la revue scientifique Science
@fr
im März 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in Science
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2011
@uk
name
New Epigenetic Drivers of Cancers
@en
New Epigenetic Drivers of Cancers
@nl
type
label
New Epigenetic Drivers of Cancers
@en
New Epigenetic Drivers of Cancers
@nl
prefLabel
New Epigenetic Drivers of Cancers
@en
New Epigenetic Drivers of Cancers
@nl
P2860
P356
P1433
P1476
Cancer. New epigenetic drivers of cancers
@en
P2093
C David Allis
P2860
P304
P356
10.1126/SCIENCE.1203280
P407
P577
2011-03-01T00:00:00Z